Stockscreener 앱 받기
8.18
2.12%
0.17
시간 외 거래:
8.25
0.07
+0.86%
Neogenomics Inc 주식(NEO)의 최신 뉴스
NeoGenomics (NEO) launches RaDaR ST to capture share in $20B MRD market - MSN
NeoGenomics (NEO) Launches RaDaR ST to Capture Share in $20B MRD Market - Insider Monkey
NeoGenomics slides more than 5% despite fourth-quarter earnings beat - MSN
NeoGenomics, Inc. (NASDAQ: NEO) Q4 2025 earnings call transcript - MSN
11 Most Buzzing Stocks to Buy with the Highest Upside Potential - Insider Monkey
NeoGenomics offers preview of booth presence at USCAP2026 - Traders Union
NeoGenomics Beats Investor Suit Over Growth Driver Claims - Law360
Will Medicare Coverage for PanTracer LBx Liquid Biopsy Shift NeoGenomics' (NEO) Diagnostic Narrative? - Yahoo Finance
NeoGenomics, Inc. Experiences Evaluation Revision Amidst Market Dynamics and Performance Challenges - Markets Mojo
Assessing NeoGenomics (NEO) Valuation After Recent Share Price Weakness - simplywall.st
NeoGenomics’ PanTracer LBx test receives Medicare coverage By Investing.com - Investing.com South Africa
NEO NeoGenomics, Inc. Maintained: Cowen Buy, William Blair Market Perform Mar 2026 - Meyka
NeoGenomics, Natera, and Amphastar Pharmaceuticals Shares Skyrocket, What You Need To Know - Yahoo Finance
NeoGenomics Gets Dismissal of Cancer Test Misrepresentation Suit - Bloomberg Law News
NeoGenomics’ PanTracer LBx Receives Medicare Coverage, Expanding Access to Comprehensive Liquid Biopsy Profiling - BioSpace
William Blair reiterates Market Perform on Neogenomics stock after Medicare coverage decision - Investing.com
Neogenomics stock gets Medicare coverage for blood-based test By Investing.com - Investing.com Canada
Neogenomics stock gets Medicare coverage for blood-based test - Investing.com
NeoGenomics test gains Medicare coverage for cancer care - Gulfshore Business
NeoGenomics’ PanTracer LBx Receives Medicare Coverage, Expanding Access to Comprehensive Liquid Biop - pharmiweb.com
Neogenomics stock gets MolDX reimbursement for cancer test - Investing.com
Neogenomics IncPantracer Lbx Test Receives Medicare Coverage Under CMS Moldx Program - TradingView
NeoGenomics’ PanTracer LBx test receives Medicare coverage - Investing.com
NeoGenomics, Inc. $NEO Stock Position Increased by First Light Asset Management LLC - MarketBeat
Silverback Asset Management LLC Invests $1.55 Million in NeoGenomics, Inc. $NEO - MarketBeat
NeoGenomics to present at NextGen Omics Spatial and Data U.S. 2026 on immunotherapy resistance mapping - Traders Union
Liquid Biopsy Market to Reach US$28.20 Billion by 2033 at 12.8% - openPR.com
NeoGenomics (NEO) Price Target Increased by 21.45% to 12.44 - MSN
NeoGenomics announces launch of new cancer assay PanTracer Pro - MSN
Trend Review: Can NeoGenomics Inc keep up with sector leadersQuarterly Trade Summary & Weekly Return Optimization Alerts - baoquankhu1.vn
NeoGenomics (NASDAQ:NEO) Stock Price Down 7.9%Should You Sell? - MarketBeat
Greenhouse Funds LLLP Acquires 789,510 Shares of NeoGenomics, Inc. $NEO - MarketBeat
NeoGenomics at Leerink Conference: Strategic Growth Focus By Investing.com - Investing.com India
NeoGenomics at Leerink Conference: Strategic Growth Focus - Investing.com
Investment Recap: Is NeoGenomics Inc gaining market share2026 Volatility Report & Long Hold Capital Preservation Tips - baoquankhu1.vn
Insider Sell: Can NeoGenomics Inc deliver alphaMarket Activity Report & Expert Verified Movement Alerts - baoquankhu1.vn
NeoGenomics Q4 2025 earnings preview - MSN
GW&K Investment Management LLC Cuts Stock Position in NeoGenomics, Inc. $NEO - MarketBeat
Royce & Associates LP Sells 860,000 Shares of NeoGenomics, Inc. $NEO - MarketBeat
Vanguard Group Inc. Has $107.34 Million Stock Position in NeoGenomics, Inc. $NEO - MarketBeat
NeoGenomics, Inc. $NEO Shares Sold by Segall Bryant & Hamill LLC - MarketBeat
NeoGenomics (NEO) accounting chief granted new options and RSUs - Stock Titan
Equity awards expand NeoGenomics (NEO) EVP Olivo’s stock-based pay - Stock Titan
NeoGenomics (NEO) COO receives new stock option and RSU grants - Stock Titan
Major equity grants to NeoGenomics (NEO) CEO Anthony P. Zook - Stock Titan
NeoGenomics at TD Cowen Conference: Strategic Growth Insights By Investing.com - Investing.com Canada
NeoGenomics at TD Cowen Conference: Strategic Growth Insights - Investing.com South Africa
A Look At NeoGenomics (NEO) Valuation After The RaDaR ST Assay Launch - simplywall.st
NeoGenomics Stock Price Drops Below 200-Day Average - National Today
NeoGenomics (NASDAQ:NEO) Stock Price Crosses Below 200-Day Moving AverageHere's What Happened - MarketBeat
NeoGenomics (NEO) CFO Abhishek Jain granted options and RSUs - Stock Titan
Oversold Conditions For NeoGenomics (NEO) - Nasdaq
NEO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
NEO Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Earnings are out: How did SWFL companies perform? - Naples Daily News
Natera, NeoGenomics Unit End Patent Suit Over Lung Cancer Test - Bloomberg Law News
0.55%
2.50%
자본화:
|
볼륨(24시간):